Stimulation of in vitro angiogenesis by tetrahydrobiopterin in bovine aortic endothelial cells

Japanese Journal of Pharmacology

Volumn 80, Issue 2, 1999, Pages 177-180

  Shimizu, Shunichi ^a   Yasuda, Masako ^a   Ishii, Masakazu ^a   Nagai, Tsutomu ^a   Kiuchi, Yuji ^a   Yamamoto, Toshinori ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Proliferation; Tetrahydrobiopterin

Indexed keywords

COLLAGEN TYPE 1; N ACETYLSEROTONIN; SEPIAPTERIN; SEPIAPTERIN REDUCTASE; TETRAHYDROBIOPTERIN;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; CATTLE; CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; NONHUMAN; VASCULAR ENDOTHELIUM;

EID: 0032801010     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.80.177     Document Type: Article

References (15)

1. Weihrauch D, Tessmer JP, Kersten JR, Pagel PS, Hettrick DA, Chilian WM and Warltier DC: Ischemia-induced coronary collateral angiogenesis. Adv Exp Med Biol 454, 281-286 (1998)
2. LaManna JC, Kuo NT and Lust WD: Hypoxia-induced brain angiogenesis. Signals and consequences. Adv Exp Med Biol 454, 287-293 (1998)
3. 2-induecd endothelial cell injury. Pharmacol Toxicol 82, 280-286 (1998)
4. Shimizu S, Ishii M, Kawakami Y, Momose K and Yamamoto T: Protective effects of tetrahydrobiopterin against nitric oxide-induced endothelial cell death. Life Sci 63, 1585-1592 (1998)
5. Ishii M, Shimizu S, Momose K and Yamamoto T: SIN-1-induced cytotoxicity in cultured endothelial cells involves reactive oxygen species and nitric oxide: protective effect of sepiapterin. J Cardiovasc Pharmacol 33, 295-300 (1999)
6. Kojima S, Ona S, lizuka I, Arai T, Mori H and Kubota K: Antioxidative activity of 5,6,7,8-tetrahydrobiopterin and its inhibitory effect on paraquat-induced cell toxicity in cultured rat hepatocytes. Free Radic Res 23, 419-430 (1995)
7. Anastasiadis PZ, States JC, Imerman BA, Louie MC, Kuhn DM and Levine RA: Mitogenic effects of tetrahydrobiopterin in PC12 cells. Mol Pharmacol 49, 149-155 (1996)
8. 2-induecd endothelial cell injury. Br J Pharmacol 113, 564-568 (1994)
9. Lee DY, Yasuda M, Yamamoto T, Yoshida T and Kuroiwa Y: Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro. Life Sci 60, 127-134 (1997)
10. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T and Kuroiwa Y: Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ets-1 in endothelial cells. Life Sci 64, 249-258 (1999)
11. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267, 10931-10934 (1992)
12. Lopez JJ, Laham RJ, Stamler A, Pearlman JD, Bunting S, Kaplan A, Carrozza JP, Sellke FW and Simons M: VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc Res 40, 272-281 (1998)
13. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K and Isner JM: Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804 (1998)
14. Ishii M, Shimizu S, Yamamoto T, Momose K and Kuroiwa Y: Acceleration of oxidative stress-induced endothelial cell death by nitric oxide synthase dysfunction accompanied with decrease in tetrahydrobiopterin content. Life Sci 61, 739-747 (1997)
15. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 273, 25804-25808 (1998)